These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23817331)

  • 21. Destination based errors in chloroquine malaria chemoprophylaxis vary based on provider specialty and credentials.
    Helfrich AM; Fraser JA; Hickey PW
    Travel Med Infect Dis; 2022; 47():102310. PubMed ID: 35307541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review: Malaria chemoprophylaxis for travelers to Latin America.
    Steinhardt LC; Magill AJ; Arguin PM
    Am J Trop Med Hyg; 2011 Dec; 85(6):1015-24. PubMed ID: 22144437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost considerations of malaria chemoprophylaxis including use of primaquine for primary or terminal chemoprophylaxis.
    Bryan JP
    Am J Trop Med Hyg; 2006 Sep; 75(3):416-20. PubMed ID: 16968914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malaria Surveillance - United States, 2014.
    Mace KE; Arguin PM
    MMWR Surveill Summ; 2017 May; 66(12):1-24. PubMed ID: 28542123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-free Holidays: Compliance, Tolerability, and Acceptability of a 3-Day Atovaquone/Proguanil Schedule for Pretravel Malaria Chemoprophylaxis in Australian Travelers.
    Lau CL; Ramsey L; Mills LC; Furuya-Kanamori L; Mills DJ
    Clin Infect Dis; 2019 Jun; 69(1):137-143. PubMed ID: 30281083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in antimalarial prescriptions in Australia 2002 to 2005.
    Leggat PA
    J Travel Med; 2008; 15(5):302-6. PubMed ID: 19006502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
    Overbosch D; Schilthuis H; Bienzle U; Behrens RH; Kain KC; Clarke PD; Toovey S; Knobloch J; Nothdurft HD; Shaw D; Roskell NS; Chulay JD;
    Clin Infect Dis; 2001 Oct; 33(7):1015-21. PubMed ID: 11528574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malaria protection in Sierra Leone during the Ebola outbreak 2014/15; The UK military experience with malaria chemoprophylaxis Sep 14-Feb 15.
    Tuck J; Williams J
    Travel Med Infect Dis; 2016; 14(5):471-474. PubMed ID: 27474994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antimalarial chemoprophylaxis in the French army: development from 1986 to 2001].
    Baudon D; Michel R; Meynard JB; Keundjian A; Boutin JP
    Med Trop (Mars); 2001; 61(1):51-5. PubMed ID: 11584656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Well-tolerated chemoprophylaxis uniformly prevented Swedish soldiers from Plasmodium falciparum malaria in Liberia, 2004-2006.
    Andersson H; Askling HH; Falck B; Rombo L
    Mil Med; 2008 Dec; 173(12):1194-8. PubMed ID: 19149338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malaria surveillance--United States, 2012.
    Cullen KA; Arguin PM;
    MMWR Surveill Summ; 2014 Dec; 63(12):1-22. PubMed ID: 25474160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of malaria prevention measures by North American and European travelers to East Africa.
    Lobel HO; Baker MA; Gras FA; Stennies GM; Meerburg P; Hiemstra E; Parise M; Odero M; Waiyaki P
    J Travel Med; 2001; 8(4):167-72. PubMed ID: 11703900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malaria Surveillance - United States, 2013.
    Cullen KA; Mace KE; Arguin PM;
    MMWR Surveill Summ; 2016 Mar; 65(2):1-22. PubMed ID: 26938139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of short prophylactic course of atovaquone-proguanil in travelers to sub-saharan Africa.
    Leshem E; Meltzer E; Stienlauf S; Kopel E; Schwartz E
    J Travel Med; 2014; 21(2):82-5. PubMed ID: 24298915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi.
    Steketee RW; Wirima JJ; Slutsker L; Roberts JM; Khoromana CO; Heymann DL; Breman JG
    Am J Trop Med Hyg; 1996; 55(1 Suppl):24-32. PubMed ID: 8702034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic use of antimalarials during pregnancy.
    Irvine MH; Einarson A; Bozzo P
    Can Fam Physician; 2011 Nov; 57(11):1279-81. PubMed ID: 22084457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa.
    Lachish T; Bar-Meir M; Eisenberg N; Schwartz E
    J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27625401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of US military research programs in the development of US Food and Drug Administration--approved antimalarial drugs.
    Kitchen LW; Vaughn DW; Skillman DR
    Clin Infect Dis; 2006 Jul; 43(1):67-71. PubMed ID: 16758420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vivax Malaria Chemoprophylaxis: The Role of Atovaquone-Proguanil Compared to Other Options.
    Meltzer E; Rahav G; Schwartz E
    Clin Infect Dis; 2018 May; 66(11):1751-1755. PubMed ID: 29228132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malaria chemoprophylaxis: what do the travelers choose, and how does pretravel consultation influence their final decision.
    Senn N; D'Acremont V; Landry P; Genton B
    Am J Trop Med Hyg; 2007 Dec; 77(6):1010-4. PubMed ID: 18165513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.